Cargando…

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees

OBJECTIVES: A specific and sensitive automated chemiluminescent immunoassay (CLIA) was developed to detect neutralizing antibody (NAb) levels. This assay can be used for the diagnosis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, treatment and vaccine evaluation. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Binjian, Su, Xibin, Yu, George, Yang, Shuling, Wang, Feng, Huang, Tao, Zhou, Liuyong, Hui, Zhiqiang, Liao, Yixian, Qiu, Yuan, Huang, Juan, Gao, Hong, Liu, Justin, Zhong, Yaoqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660141/ https://www.ncbi.nlm.nih.gov/pubmed/34896578 http://dx.doi.org/10.1016/j.ijid.2021.12.316

Ejemplares similares

Corrigendum to ‘An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ’ [International Journal of Infectious Diseases, Volume 115, 2022, Pages 116-125, ISSN 1201-9712]()
por: Liu, Binjian, et al.
Publicado: (2022)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia
por: Sekirov, Inna, et al.
Publicado: (2021)

Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
por: Klüpfel, Julia, et al.
Publicado: (2022)

An Automated and Highly Sensitive Chemiluminescence Immunoassay for Diagnosing Mushroom Poisoning
por: Zhu, Jianyu, et al.
Publicado: (2021)

Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma
por: Nishikawa, Yukihiro, et al.
Publicado: (2022)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID‐19 cohorts by chemiluminescent immunoassays
por: Dou, Xiaowen, et al.
Publicado: (2022)

Effect of storage temperatures simulating transport conditions of nasopharyngeal swabs on the results of a chemiluminescence immunoassay (CLIA) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen
por: Kanta, Poonam, et al.
Publicado: (2023)

Chemiluminescence Immunoassay to Detect Anti‐HTLV‐I Antibodies
por: Kamihira, Shimeru, et al.
Publicado: (1993)

Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody
por: Yang, Shuo, et al.
Publicado: (2019)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Validation of a fully automated chemiluminescent immunoassay for cattle serum and plasma progesterone measurement
por: Megahed, Ameer A., et al.
Publicado: (2023)

Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population
por: Yin, Qiangling, et al.
Publicado: (2021)

The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies
por: Hou, Xiuzhu, et al.
Publicado: (2020)

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
por: Beranger, Nicolas, et al.
Publicado: (2020)

The Detection of SARS-CoV2 Antigen in Wastewater Using an Automated Chemiluminescence Enzyme Immunoassay
por: Thongpradit, Supranee, et al.
Publicado: (2022)

Development of an automated chemiluminescent immunoassay for cancer antigen 72–4 and the evaluation of its analytical performance
por: Yanagihara, Fusamitsu, et al.
Publicado: (2023)

Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies
por: Parai, Debaprasad, et al.
Publicado: (2021)

Comparison of Chemiluminescence Enzyme Immunoassay (Cl-ELISA) with Colorimetric Enzyme Immunoassay (Co-ELISA) for Imidacloprid Detection in Vegetables
por: Zhai, Rongqi, et al.
Publicado: (2023)

A Chemiluminescent Immunoassay for Osteocalcin in Human Serum and a Solution to the “Hook Effect”
por: Han, Shuang, et al.
Publicado: (2020)

CLIA-certified next-generation sequencing analysis in the cloud
por: Zhang, Ying, et al.
Publicado: (2012)

Assessment of the measurement of canine and feline serum fibroblast growth factor-23 concentrations by automated chemiluminescence immunoassay
por: MIYAKAWA, Hirosumi, et al.
Publicado: (2021)

Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis
por: Mo, Xiaohui, et al.
Publicado: (2010)

Chemiluminescence based immunoassay for the detection of heroin and its metabolites
por: Singh, Smritee, et al.
Publicado: (2018)

Highly Specific Chemiluminescence Immunoassay for the Determination of Chloramphenicol in Cosmetics
por: Li, Qiyan, et al.
Publicado: (2019)

Evaluation of a Chemiluminescent Immunoassay for Measurement of Equine Insulin
por: Carslake, H.B., et al.
Publicado: (2017)

Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis
por: Ishii, Toshiaki, et al.
Publicado: (2021)

Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein
por: Xu, Ye, et al.
Publicado: (2022)

Comparison and evaluation of Abbott chemiluminescent microparticle immunoassay and ChIVD light‐initiated chemiluminescent assay in the detection of Treponema pallidum antibody
por: Chen, Xiaohui, et al.
Publicado: (2020)

Development of a Chemiluminescence Immunoassay for Quantification of 25-Hydroxyvitamin D in Human Serum
por: Han, Shuang, et al.
Publicado: (2020)

CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis
por: Rieken, Autumn, et al.
Publicado: (2021)

Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays
por: Oakes, Brendan, et al.
Publicado: (2011)

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
por: Martinez, David R., et al.
Publicado: (2020)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Development of a Sensitive Chemiluminescence Immunoassay for the Quantification of Folic Acid in Human Serum
por: Chen, Xiang, et al.
Publicado: (2019)

Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
por: Cinquanta, Luigi, et al.
Publicado: (2017)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Buildout and integration of an automated high-throughput CLIA laboratory for SARS-CoV-2 testing on a large urban campus
por: Landaverde, Lena, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies
por: Gaber, Yasmine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8l6kbsl1djqvnr91iq44j40p1r